Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating single-day or single-dose famciclovir for recurrent herpes labialis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Labialis

Drugs mentioned

• Famvir (famciclovir)

Snippet

Sponsor: Novartis | Conditions: Recurrent Herpes Labialis | Phase 4 | Status: COMPLETED